ArticleJPRAS open2025
Multiple synchronous primary melanomas; A case report.
Article in JPRAS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous melanoma is a highly aggressive form of skin cancer, responsible for >90 % of deaths related to skin tumors, despite accounting for only a small proportion of total cutaneous tumors. Cutaneous melanoma is the fifth most commonly diagnosed cancer in both females and males and there is an annual increase of around 3-7 %. In recent years, survival rates have improved due to health education campaigns, prevention strategies and the development of new treatments for advanced disease. Melanoma patients have an increased risk of developing a new melanoma, although the risk is still low. Most new melanomas are diagnosed within 5 years of the first melanoma. A small fraction of patients are diagnosed with more than one melanoma within 3 months of the first melanoma, referred to as synchronous melanomas. As this is a rare phenomenon, the available literature remains limited. Some studies have shown improved survival in this group and that the subsequent melanoma was significantly thinner; however further research is needed to fully understand this phenomenon. Here we present a case with a patient with six synchronous melanomas diagnosed within 19 days. The patient underwent genetic screening but no pathogenic gene variants were found. This case highlights the importance of thorough skin examination at the time of melanoma diagnosis. To our knowledge, this is the first reported case of six synchronous melanomas in the absence of identifiable genetic predisposition. The case demonstrates the need for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.